During the past decade, Cardiovascular Associates conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 10 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Associates" #1 sponsor was "Pfizer" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Actelion" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Associates" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canadian Heart Research Centre" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Associates" are "Peripheral Arterial Disease" (4 trials), "Atherosclerosis" (3 trials), "Myocardial Infarction" (3 trials), "Pulmonary Arterial Hypertension" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Cardiovascular Associates" in a lesser frequency.

Most popular intervention types in "Cardiovascular Associates" are "Drug" (13 trials), "Device" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apixaban" (2 trials), "Simvastatin" (2 trials), "AGI-1067" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Associates" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Associates". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Cardiovascular Associates, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".